ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Cancer treatments can have major effect on hair color – Hanford Sentinel

Continue reading

2017-09-28 Michael Zand NEWS

A biobank of reversible mutant embryonic stem cells – Phys.Org

Cancer treatments can have major effect on hair color
Hanford Sentinel
Your question about cancer therapy returning color to gray hair makes us think you’re talking about recent news stories emerging from the field of immunotherapy. Unlike chemotherapy, which directly targets cancer cells, immunotherapy drugs enlist a …

and more »

Continue reading

2017-09-28 Michael Zand NEWS

Cancer patient found a stem cell donor in Vietnam. US is finally granting her a visa. – Washington Post

Washington PostCancer patient found a stem cell donor in Vietnam. US is finally granting her a visa.Washington PostThe bureaucratic hits kept coming, and it was looking grim for Helen Huynh and her family. The 61-year-old woman from Garden Grove, Calif… Continue reading

2017-09-28 Michael Zand NEWS

‘Chemical surgery’ used to mend harmful mutations in human embryos – The Guardian


Phys.Org

A biobank of reversible mutant embryonic stem cells
Phys.Org
Scientist at IMBA developed a biobank of revertible, mutant embryonic stem cells, published in the current issue of Nature. This cell bank – called Haplobank – contains over 100,000 mutated, conditional mouse embryonic stem cell lines, targeting about …

Continue reading

2017-09-28 Michael Zand NEWS

‘Chemical surgery’ used to mend harmful mutations in human embryos – The Guardian


The Guardian

‘Chemical surgery’ used to mend harmful mutations in human embryos
The Guardian
In the past decade, scientists have developed a range of powerful tools to edit the genetic code, the most popular of which is called Crispr-Cas9. The method uses enzymes to make precision cuts in faulty genes which the body can then repair with the …
DNA surgery on embryos removes diseaseBBC News
New gene editor used to fix disease in embryos: studyPhys.Org
Incredibly, Scientists Have Cured An Embryo Of A Life-Threatening Disease By Altering Its DNAHuffPost UK
IFLScience –Telegraph.co.uk –Week Facts
all 17 news articles »
Continue reading

2017-09-28 Michael Zand NEWS

Japanese collaborations reach new heights – Imperial College London


The Guardian

‘Chemical surgery’ used to mend harmful mutations in human embryos
The Guardian
In the past decade, scientists have developed a range of powerful tools to edit the genetic code, the most popular of which is called Crispr-Cas9. The method uses enzymes to make precision cuts in faulty genes which the body can then repair with the …
DNA surgery on embryos removes diseaseBBC News
New gene editor used to fix disease in embryos: studyPhys.Org
Incredibly, Scientists Have Cured An Embryo Of A Life-Threatening Disease By Altering Its DNAHuffPost UK
IFLScience –Telegraph.co.uk –Week Facts
all 17 news articles »
Continue reading

2017-09-28 Michael Zand NEWS

Oxford Spinout goes for $75M IPO on Nasdaq to Fund Gene Therapy Programs – Labiotech.eu (blog)


Imperial College London

Japanese collaborations reach new heights
Imperial College London
The 2nd Tokyo Tech-Imperial Workshop, brought together some of the world’s leading researchers to explore new collaborations in bioscience and its links with technology, encompassing expertise in synthetic biology, data science and neurotechnology.

Continue reading

2017-09-28 Michael Zand NEWS

Global Immunotherapy Drugs Market Growth Rate Analysis 2017-2022 – Medgadget (blog)

Medgadget (blog)Global Immunotherapy Drugs Market Growth Rate Analysis 2017-2022Medgadget (blog)The market study on Global Immunotherapy Drugs Market 2017 Research Report studies current as well as future aspects of the Immunotherapy Drugs Market prima… Continue reading

2017-09-28 Michael Zand NEWS
  • 1
  • …
  • 1,132
  • 1,133
  • 1,134
  • 1,135
  • 1,136
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Labiotech.eu (blog)

Oxford Spinout goes for $75M IPO on Nasdaq to Fund Gene Therapy Programs
Labiotech.eu (blog)
Nightstar has gone public on the American market with the aim of raising $75M for its gene-based retinal disease cures. Spun out from Oxford in 2013, Nightstar is developing and commercializing one-shot gene therapies for various eye diseases that …
Nightstar Therapeutics (Nasdaq: NITE) to Ring The Nasdaq Stock Market Closing Bell in Celebration of Its IPONasdaq
Syncona’s Nightstar reveals details on US IPODIGITALLOOK

all 5 news articles »